Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Guo-jiang Hou"'
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 125:669-676
EXf, a glucagon-like peptide 1 (GLP-1) receptor agonist, stimulates β-cell proliferation and reduces apoptosis in diabetic animal models, but the underlying mechanisms are not fully understood. We constructed a FoxO1-GFP fusion protein expression pl
Autor:
Quan Liu, Zhufang Shen, Caina Li, Guo-jiang Hou, Shousheng Yan, Sujuan Sun, Miaomiao Yang, Shuainan Liu, Yi Huan, Dongan Yu
Publikováno v:
Biological & Pharmaceutical Bulletin. 40:1399-1408
GW002 is a recombinant protein engineered by fusing the C-terminal region of human glucagon-like peptide-1 (GLP-1) to the N-terminal region of human serum albumin (HSA) with a peptide linker. This study aims to evaluate its anti-diabetic effects both
Autor:
Shuainan Liu, Ling Li, Quan Liu, Guo-jiang Hou, Jun Peng, Lin-yi Li, Weiping Liu, Zhufang Shen, Sujuan Sun, Li-hui Gao, Yi Huan, Caina Li
Publikováno v:
Biological Trace Element Research. 153:329-339
Vanadium compounds maintain euglycemic effects in diabetic rats long after drug withdrawal and bis(α-furancarboxylato)oxovanadium(IV) (BFOV) possesses potent antidiabetic effects in diabetic rats. Here, we investigated the treatment and posttreatmen
Publikováno v:
Experimental & Clinical Endocrinology & Diabetes; 2017, Vol. 125 Issue 10, p669-676, 8p
Autor:
Yi Huan, Sujuan Sun, Guo-jiang Hou, Shuainan Liu, Quan Liu, Caina Li, Lin-yi Li, Zhufang Shen, Shaocong Hou
Publikováno v:
Peptides. 40
EXf is a C-terminally truncated fragment of Exendin-4 with two amino acid substitutions. Previous studies showed that EXf controls plasma glucose level acting as a glucagon-like peptide 1 (GLP-1) receptor agonist. The purpose of this study was to eva
Publikováno v:
2006 8th international Conference on Signal Processing; 2006, pN.PAG, 1p
Autor:
Michael Loewe
This is a unique and conclusive reference work about the 6,000 individual men and women known to us from China's formative first empires. Over decennia Michael Loewe (Cambridge, UK) has painstakingly collected all biographical information available.